CADUET® (amlodipine / atorvastatin) is indicated in the following patient populations:
1. Patients with a higher cardiovascular risk due to the presence of two modifiable risk factors, hypertension and dyslipidemia; me
2. Patients with increased cardiovascular risk due to the presence of symptomatic CHD (coronary artery disease) expressed as angina with the additional modifiable risk factor of dyslipidemia; me
3. Prevention of cardiovascular complications in hypertensive patients (see Prevention of cardiovascular complications).
In patients with multiple cardiovascular risk factors, CADUET® (amlodipine / atorvastatin) is indicated for:
Hypertension: The amlodipine component is indicated for first-line treatment of hypertension and can be used as a single agent to control blood pressure in most patients.
Patients not adequately controlled with a single antihypertensive agent (other than amlodipine) may benefit from the addition of the amlodipine component of CADUET® (amlodipine / atorvastatin), just as they would benefit from the addition of amlodipine alone.
Amlodipine is also indicated to reduce the risk of fatal coronary heart disease and non-fatal myocardial infarction and to reduce the risk of stroke.
Coronary artery disease: The amlodipine component is indicated to reduce the risk of coronary revascularization procedures and the need for hospitalization for angina in patients with coronary artery disease.
Chronic stable angina: The amlodipine component is indicated for first-line treatment of myocardial ischemia, whether it is the cause of fixed obstruction (stable angina) and / or vasospasm / vasoconstriction (prinzmetal or variable angina) of the coronary vasculature.
CADUET® (amlodipine / atorvastatin) can be used when the clinical presentation suggests a possible vasospastic / vasoconstrictor component but it has not been confirmed that there is vasospasm / vasoconstruction.
CADUET® (amlodipine / atorvastatin) can be used alone or in combination with other antianginal drugs in patients with angina refractory to nitrates and / or adequate doses of ß-blockers.
Dyslipidemia: The atorvastatin component is indicated as an adjunct to the diet for the treatment of patients with elevated values of total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides and to increase HDL cholesterol in patients with primary hypercholesterolemia (heterozygous hypercholesterolemia in familial and non-familial ) combined (mixed) hyperlipidemia (Fredrickson types IIa and IIb), high levels of serum triglycerides (Fredrickson type IV), and in patients with dysbetalipoproteinemia (Fredrickson type III) who do not respond adequately to diet.
The atorvastatin component is also indicated to reduce total cholesterol and LDL cholesterol in patients with homozygous familial hypercholesterolemia.
Prevention of cardiovascular complications:
In patients without clinically evident cardiovascular disease and with or without dyslipidemia but with multiple risk factors for coronary heart disease such as smoking, hypertension, low HDL-C diabetes or a family history of early coronary disease atorvastatin is indicated for:
- Reduce the risk of fatal coronary disease and non-fatal myocardial infarction.
- Reduce the risk of stroke.
- Reduce the risk of revascularization procedures and angina pectoris.
In patients with clinically evident heart disease atorvastatin is indicated for:
- Reduce the risk of non-fatal myocardial infarction.
- Reduce the risk of fatal and non-fatal stroke.
- Reduce the risk in revascularization procedures.
- Reduce the risk of hospitalization for congestive heart failure.
- Reduce the risk of angina.
Pediatric patients (10 to 17 years old): Atorvasta
Tina is indicated as a dietary adjunct to reduce total cholesterol, LDL-C, and apo B levels in boys and girls 10 to 17 years of age with heterozygous familial hypercholesterolaemia if the following observations are present after adequate trial with dietary therapy :
to. LDL-C remains ³ 190 mg / dL or
b. LDL-C remains ³ 160 mg / dL and:
• there is a positive family history of premature cardiovascular disease or
• Two more distinct CVD risk factors are present in the pediatric patient.
What shipping methods do you offer?
Currently there is only one shipping method available: regular airmail delivery (15-24 business days) via Mexican postal service, USPS, CANADA POST, and PARCEL FORCE.
Regular airmail is an inexpensive and reliable option.
Please note that while regular airmail can also be tracked in most cases, the tracking information is available only on delivery (or attempted delivery) of the order. This allows us to see if your order was delivered successfully, but does not provide real-time delivery details.
What are your shipping rates and policies?
At the moment we offer 1 shipping option:
Regular Airmail Delivery (15-24 business days)
Once your order has been shipped, we will send you an email to notify you that your product has left our facilities. From this point on, your product is only 15-24 business days.
Please note that orders are shipped on business days only (Monday through Friday, excluding holidays).
You can view our shipping rate and other information after selecting a particular product.
Do you ship internationally?
In what currency is my purchase transaction received?
The currency used will be the US dollar.
How will my medication be packaged?
Your order will be properly packaged for your protection in transit to destination.
Where are the medications shipped from?
We ship from our office in Acapulco, Gro. Mexico
Where are the drugs you have to sell made?
Most of the drugs we offer are manufactured in Mexico, some are manufactured in countries such as Germany, England, France and others, all manufactured by large multinational laboratories legally established in Mexico.
What is the expiration date of the medications I receive?
We offer the guarantee that your product will have at least 10 months of use at the time of sale, however most of the drugs we sell have an expiration date greater than 1 to 2 years
What is your return policy?
Read the refund and cancellation policy
What forms of payment do you accept?
The payment options we have for clients are payments with a Credit or Debit card through:
We are unable to accept credit or debit card payments as VISA and Mastercard policies (do not allow pharmacies established outside the US to sell drugs to US customers).
How do I place an order?
When you click on an ADD TO CART link, you will be directed to our secure server where you will be registered as our customer. After selecting the required product and its quantity, you will be sent an email with the information of your purchase and the information to make the payment.
What happens once I send my order?
If your payment is received and identified, you will immediately receive an order confirmation email and another email once your order has been shipped.
How do I check the status of my order?
After making your purchase, you will receive an email with your order tracking information. This email contains information about the purchase and a link to the official pages of SEPOMEX, USPS, CANADA POST and PARCEL FORCE.
We are committed to protecting your privacy with the highest level of security possible. All your personal information, including name and address, is encrypted so that it cannot be read as it is transmitted from your computer to our server. We use the Secure Socket Layer (SSL) protocol which enables end-to-end data protection.